Japan Tobacco Inc. (JAT.VI)
- Previous Close
27.63 - Open
27.76 - Bid --
- Ask --
- Day's Range
27.55 - 27.81 - 52 Week Range
22.35 - 27.81 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
49.123B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
44.44 - EPS (TTM)
0.62 - Earnings Date Jul 31, 2025
- Forward Dividend & Yield 1.23 (4.43%)
- Ex-Dividend Date Jun 27, 2025
- 1y Target Est
--
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.
www.jt.comRecent News: JAT.VI
View MorePerformance Overview: JAT.VI
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JAT.VI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JAT.VI
View MoreValuation Measures
Market Cap
49.27B
Enterprise Value
53.94B
Trailing P/E
44.44
Forward P/E
16.81
PEG Ratio (5yr expected)
0.55
Price/Sales (ttm)
2.46
Price/Book (mrq)
2.11
Enterprise Value/Revenue
2.70
Enterprise Value/EBITDA
14.27
Financial Highlights
Profitability and Income Statement
Profit Margin
5.54%
Return on Assets (ttm)
2.77%
Return on Equity (ttm)
4.61%
Revenue (ttm)
3.24T
Net Income Avi to Common (ttm)
179.45B
Diluted EPS (ttm)
0.62
Balance Sheet and Cash Flow
Total Cash (mrq)
809.36B
Total Debt/Equity (mrq)
43.11%
Levered Free Cash Flow (ttm)
113.1B